Home » Illumina Issues Second Shareholder Letter to Reject Roche

Illumina Issues Second Shareholder Letter to Reject Roche

Mar 26, 2012

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – On the heels of Roche's extension of its hostile takeover bid and in anticipation of its annual shareholders' meeting next month, Illumina today sent a second letter to its shareholders to vote reject Roche's efforts to acquire the San Diego-based firm.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Warren Releases Genetic Ancestry Results

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Thirty-One Recommended for Removal

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz Dies

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

This Week in PLOS

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.

What's Popular?

In Clinical Sequencing

  1. Undiagnosed Diseases Network Reports Diagnostic Rates, Impact on Treatment

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.